« Back
Home /
STAT3 Inhibitor XVIII, BP-1-102

STAT3 Inhibitor XVIII, BP-1-102

Item no.	DCC-DC8040-250mg
Manufacturer	DCChemicals
CASRN	1334493-07-0
Amount	250 mg
Quantity options	100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Inhibitors
Specific against	other
Purity	>99%
Smiles	S(C1C(=C(C(=C(C=1F)F)F)F)F)(N(C([H])([H])[H])C([H])([H])C(N(C1C([H])=C([H])C(C(=O)O[H])=C(C=1[H])O[H])C([H])([H])C1C([H])=C([H])C(=C([H])C=1[H])C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])=O)(=O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BP-1-102,BP1-102,BP 1-102.
Similar products	1334493-07-0
Available
Manufacturer - Applications	BP-1-102 is a potent, orally bioavailable and selective STAT3 inhibitor.BP-1-102 could enhance the transfection efficiency to 2-fold to 5-fold of Lipofectamine 3000 and LNP, all of which are currently approved for clinical use in the treatment of the most common malignant tumors.
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	626, 5915
Note	For research and scientific purpose only, not for human use.
Chemical name	4-(N-(4-cyclohexylbenzyl)-2-(2, 3, 4, 5, 6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 1/1/2026

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer